# Clark Laboratories, Inc.

- Location (FDA's records): Blairstown, NJ
- FDA decisions: 14 (1992–1998): 14 510(k) clearances
- Product codes: LLL (5), LSE (3), LFX (1), LLM (1), LKJ (1), LRM (1), JZO (1), DHR (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Bio-Rad Laboratories, Inc.: 2 (https://510kreport.com/company/bio-rad-laboratories)

## Its most-cited devices
- K973123: EA-D Igg Elisa Test System (1998), cited by 1
- K980912: Vca Igg Elisa Test System (1998), cited by 1

## Recent decisions
- K980596: Vca Igm Elisa Test System (Jul 22, 1998)
- K980912: Vca Igg Elisa Test System (Jul 22, 1998)
- K980598: Ebna-1 Igm Elisa Test System (May 1, 1998)
- K973123: EA-D Igg Elisa Test System (Mar 26, 1998)
- K931543: Encore Ena Combined Eia (Sep 8, 1993)
- K925826: Encore Thyroglobulin Ige, Iga and Igm Eia (Jan 26, 1993)
- K923537: Encore DS-Dna (Dec 23, 1992)
- K921572: Encore SM (Dec 1, 1992)

Source page: https://510kreport.com/company/clark-laboratories